Dow Surges 100 Points; US Initial Jobless Claims Rise
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 06 2024
0mins
Source: Benzinga
- U.S. Stock Market: Dow Jones gained around 100 points, with the NASDAQ and S&P 500 also rising.
- Equities Trading: Some stocks surged significantly, like Virax Biolabs Group Limited and Latam Logistic Properties, while others dropped notably, such as Actelis Networks, Inc. and Jowell Global Ltd.
- Commodities: Oil traded up to $74.56, gold at $2,377.00, silver at $30.29, and copper at $4.6460.
- Eurozone: European shares were higher, with key interest rate cuts by the ECB and various economic indicators reported for different countries.
- Asia Pacific Markets: Asian markets closed mostly higher, with notable changes in trade surplus for Australia and market performance in Japan, China, Hong Kong, and India.
Analyst Views on VRAX
Wall Street analysts forecast VRAX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for VRAX is 1.00 USD with a low forecast of 1.00 USD and a high forecast of 1.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.263
Low
1.00
Averages
1.00
High
1.00
Current: 0.263
Low
1.00
Averages
1.00
High
1.00
About VRAX
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing ViraxImmune with the intention of providing an immunology profiling platform that assesses each individual’s immune risk profile against global viral diseases as well as helping with the early diagnosis of post-viral syndromes associated with T cell exhaustion and chronic inflammation. Its product portfolio includes ViraxClear and ViraxVet. ViraxClear offers a range of accurate diagnostic testing kits and machines. ViraxVet offers various rapid and molecular tests for small animal veterinary diagnostics. The Company is initially focused on diseases associated with post-viral syndromes, including SARS-CoV-2, Human Papillomavirus (HPV), Malaria, Hepatitis B, and Herpes (HSV-1).
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
